Advancements in the molecular pathogenesis of myelodysplastic syndrome
- 1 March 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Hematology
- Vol. 16 (2) , 70-76
Abstract
Myelodysplastic syndrome is an important hematological malignancy affecting the expanding aged population. Our understanding of the biology of this disease has been limited by the heterogeneous clinicopathological features, difficulty in creating animal models, and paucity of evidence linking molecular abnormalities to disease pathogenesis. The importance of new advances in myelodysplastic syndrome will be discussed in this review. Heightened awareness of the myelodysplastic syndrome burden has garnered rising interest in the development of new treatment strategies and investigation of the molecular basis of this complex disease. A multistep process explains the heterogeneity observed in myelodysplastic syndrome better than a single event, whereby multiple biological forces culminate in telomere erosion and genomic instability. Intrinsic genetic factors within myeloid progenitors along with extrinsic factors in the microenvironment may foster clonal selection. Specific targeted intervention at critical stages along this multistep pathway, prior to acute myeloid leukemia transformation, may produce the best clinical outcome. Newly identified molecular defects, the creation of animal models, and several advancements in our understanding of the molecular pathogenesis have dramatically improved diagnostic and therapeutic potential of myelodysplastic syndrome.Keywords
This publication has 77 references indexed in Scilit:
- Whole genome scanning as a cytogenetic tool in hematologic malignanciesBlood, 2008
- Cytogenetic features in myelodysplastic syndromesAnnals of Hematology, 2008
- Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK functionProceedings of the National Academy of Sciences, 2008
- Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AMLBlood, 2008
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screenNature, 2008
- DNA profiling by arrayCGH in acute myeloid leukemia and myelodysplastic syndromesCytogenetic and Genome Research, 2007
- Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndromeExperimental Hematology, 2007
- Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptorsBlood, 2007
- Ribosomal Protein S24 Gene Is Mutated in Diamond-Blackfan AnemiaThe American Journal of Human Genetics, 2006
- CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteinsBlood, 2006